Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer
Technology
E-180-2023
Patent ID
E-180-2023-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/469,641
IC
NCI
Date Filed
Date Issued
Patent PDF